Webinar Overview

Imagine the ability to visualize and measure phenotypic changes at the subcellular level in disease-relevant cell-based assays, all in real time, and at the earliest stages of drug discovery. That’s the power of high content imaging (HCI) using multi-parametric techniques, a vital tool that can guide your discovery program to success.

This webinar examines the following components of high content imaging and why you should use them:

  • How complex model systems using a variety of cells can improve translation to clinic
  • The impact high content screening (HCS) has on identification of new drug targets or lead compounds
  • Optimizing lead compounds using high content analysis (HCA)

We’ll also discuss a case study screening iPSC-derived neurons for modifiers of Alzheimer’s-related phenotypes in a scalable multi-parameter system.

Webinar Presenter

Shushant Jain Headshot

Shushant Jain, PhD
Group Leader Discovery
Charles River


Additional Information

We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.